Item Details

Print View

Drug Regulation Reform--Oversight: Hearing Before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-Sixth Congress, Second Session .

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment
Format
Book; Government Document
Published
Washington : U.S. G.P.O., 1980-
Language
English
Related Title
New drug approval process.
Orphan drugs.
SuDoc Number
Y 4.In 8/4:96-170
Y 4.In 8/4:96-216
Contents
  • v. 1. New drug approval process
  • v. 2. Orphan drugs.
Description
v. ; 23 cm.
Notes
  • Vol. 1: "Food and Drug Administration regulation of research, development, and marketing of drugs, June 25, 1980."
  • Vol. 2: "How can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently, June 26, 1980."
  • "Serial no. 96-170."
  • "Serial no. 96-216."
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 01994cam a2200433 a 4500
    001 u1467599
    003 SIRSI
    008 810511m19809999dcu f00010 eng d
    035
      
      
    a| (Sirsi) o07420645
    035
      
      
    a| (OCoLC)07420645
    035
      
      
    a| (GPO)81007318
    035
      
      
    a| (OCoLC)7420645
    040
      
      
    a| FTC c| FTC d| GPO
    043
      
      
    a| n-us---
    049
      
      
    a| VA@D
    074
      
      
    a| 1019
    086
    0
      
    a| Y 4.In 8/4:96-170
    086
    0
      
    a| Y 4.In 8/4:96-216
    088
      
      
    a| Serial No. 96-170 (United States. Congress. House. Committee on Interstate and Foreign Commerce)
    088
      
      
    a| Serial No. 96-216 (United States. Congress. House. Committee on Interstate and Foreign Commerce)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Interstate and Foreign Commerce. b| Subcommittee on Health and the Environment.
    245
    1
    0
    a| Drug regulation reform--oversight : b| hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ....
    260
      
      
    a| Washington : b| U.S. G.P.O., c| 1980-
    300
      
      
    a| v. ; c| 23 cm.
    500
      
      
    a| Vol. 1: "Food and Drug Administration regulation of research, development, and marketing of drugs, June 25, 1980."
    500
      
      
    a| Vol. 2: "How can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently, June 26, 1980."
    500
      
      
    a| "Serial no. 96-170."
    500
      
      
    a| "Serial no. 96-216."
    505
    0
      
    a| v. 1. New drug approval process -- v. 2. Orphan drugs.
    596
      
      
    a| 2
    610
    1
    0
    a| United States. b| Food and Drug Administration.
    650
      
    0
    a| Pharmaceutical policy z| United States.
    650
      
    0
    a| Drugs z| United States x| Testing.
    650
      
    0
    a| Pharmaceutical industry z| United States.
    740
    0
      
    a| New drug approval process.
    740
    0
      
    a| Orphan drugs.
    999
      
      
    a| Y 4.In 8/4:96-216 w| SUDOC i| 1467599-1001 l| DOC-US m| ALDERMAN t| DOCUMENT
▾See more
▴See less

Availability

Google Preview

Google Books Preview
Library Location Map Availability Call Number
Alderman US Documents (3 New) Map Available